Kunovus is a clinical-stage medtech company developing an investigational implantable spinal device for chronic low back pain.

​

We engage with mission-aligned investors and strategic partners who share our focus on rigorous clinical evidence, disciplined execution, and long-term patient impact.

​

Kunovus has attracted competitive Australian Government funding and support from leading innovation organisations to accelerate the development, manufacturing readiness and clinical translation of its motion-preserving spinal technologies. 

​

This includes $2.8 million in Cooperative Research Centres Projects (CRC-P) funding for the project Scaling Sovereign Manufacturing of Self-Curing Surgical Implants, a $1.0 million MRFF-funded BioMedTech Horizons (BMTH) grant delivered by MTPConnect, and selection for the Cicada Innovations HealthTech Hub Stride Program.